Back to Top
Sirukumab Biosimilar - Research Grade
$710.00 - $6,900.00
Sirukumab Biosimilar - Research Grade
Endotoxin
≤ 1.0 EU/mg as determined by the LAL method
Purity
>90% by SDS-PAGE
Species Reactivity
Human
Target
IL6ï؟½
Concentration
5mg/ml
Isotype
IgG1 - kappa
Host
CHO Cells
Sequence
https://www.imgt.org/mAb-DB/
Buffer
ICH3002
Uniprot
P05231
Shipping Conditions
Blue ice
Background
Interleukin-6 (IL-6) is a pleiotropic cytokine driving inflammation, acute-phase responses, and immune regulation across many disease settings. The product here is an unconjugated, non-therapeutic analog of sirukumab, a recombinant anti-IL-6 monoclonal antibody for research use only. It is manufactured to in vivo standards with low endotoxin and offered in scalable milligram to gram quantities to support bulk and high-throughput workflows. Applications include cytokine-neutralization functional assays, in vitro IL-6-signaling screens, and in vivo models of inflammatory and autoimmune disease. Consistent lot-to-lot performance makes it a dependable reagent for laboratories that consume reagents in bulk.
Purification Method
This monoclonal antibody was purified using Protein A
Formulation
Sterile, preservative-free, solution in PBS. BSA and Azide free.
Storage
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Applications
Functional Assays
Application Notes
This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Use
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Delivery Time
3-4 weeks
Write Your Own Review













